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Abstract Attention deficit hyperactivity disorder (ADHD)
in adults is increasingly recognized as a clinically important
syndrome. The aim of this study was to evaluate the psycho-
metric performance of a new scale for adult ADHD based on
the widely used Symptom Checklist 90 Revised (SCL-90-R).
Scale performance was assessed in a clinical study including
100 ADHD patients and 65 opiate-dependent patient controls,
and in the Zurich study, an epidemiological age cohort fol-
lowed over 30 years of adult life. Assessments included a
ROC analysis of sensitivity and specificity, internal consis-
tency, test–retest reliability, external validity and measure-
ment invariance over nine testing occasions. The new scale
showed a sensitivity and specificity of 75 and 54%, respec-
tively, internal consistency over 0.8 (McDonald’s omega,
Cronbach’s alpha), one-year test–retest reliabilities over 0.7,
statistically significant and substantial correlations with two
other validated self-rating scales of adult ADHD (R = 0.5 and
0.66, respectively), and an acceptable degree of longitudinal
stability (i.e., measurement invariance). The proposed scale
must be further evaluated, but these preliminary results indi-
cate it could be a useful rating instrument for adult ADHD
in situations where SCL-90-R data, but no specific ADHD
assessment, are available, such as in retrospective data analysis
or in prospective studies with limited methodical resources.
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Introduction
Although attention deficit hyperactivity disorder (ADHD)
is now recognized as a chronic condition persisting into
adulthood, it often remains undiagnosed in adults. This is
due to the fact that adults manifest the disorder’s core
symptoms in different ways, making the diagnostic process
difficult, a difficulty that is often compounded by different
comorbidities. Currently, ADHD is thought to affect about
one- to two-thirds of the affected children also in adulthood
[7, 23]. A recent epidemiological study estimated the
overall prevalence of adult ADHD to be around 4% [18,
19]. In childhood, boys are about three times more fre-
quently affected than girls, whereas in adulthood, the sex
ratio is more balanced [3, 4, 26].
Given its high persistence and the substantial impair-
ment associated with the disorder in adulthood, as well as
the widespread use of the SCL-90-R [11–13] as a self-
report checklist of symptomatic complaints in psychiatric
settings, it would be highly desirable to have a way of
using the SCL-90-R as an indicator of the presence of
ADHD. This possibility is attractive for re-analysis of data
already collected and with subjects out of reach, but also
for prospective analysis when a separate assessment of
ADHD is not feasible or desired. This includes the
important case where the SCL-90-R is used as a screening
probe for the possible presence of ADHD, which, when
positive, can be followed by a more specific assessment.
Few existing studies administered the SCL-90 R as an
outcome measure in adult ADHD [21, 30], but none of
them have attempted to use it as a diagnostic tool.
We present here a scale formed from the item pool of
the SCL-90-R that targets subjects exhibiting typical
symptoms of adult ADHD such as inattention, hyperac-
tivity and impulsivity. One aim of the present report was to
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examine the suitability of the scale for diagnostic screen-
ing. A mixed clinical sample consisting of a group of
confirmed ADHD patients and a control group of opiate-
dependent patients were studied for this purpose.
As a further aim, the psychometric properties of the
scale, particularly its temporal stability, that is, measure-
ment invariance over time, were tested in an independent
epidemiological sample from the Zurich study [2]. Loosely
speaking, measurement invariance refers to a scale’s
measuring the same thing in the same way across different
testing occasions. A simple example may serve: the Celsius
scale measures temperature in intervals of one degree
Kelvin, and the scale’s origin (zero point) is the freezing
point of water. Let us assume that we would like to mea-
sure and compare the temperature of a sample of water at
different times. This comparison would only be meaningful
if the measurement scale we used had the same intervals
and zero points at each time, that is, if it were measurement
invariant. If, for example, we used a Celsius scale at one
time and a Fahrenheit scale at another, direct comparison
of the measurements would obviously be non-sensical,
since both zero points and intervals are different. There-
fore, invariance of its measurement properties is a pre-
condition for the stability of a scale and its meaningful use
in comparing measurements obtained at different times. In
psychometry, statistical methods from structural equation
modeling are available to examine the degree to which a
scale measures a certain construct (e.g., a personality trait
or a psychiatric syndrome) reliably across different
assessment times. Similarly as in the above examples, these
methods assess the invariance of a scale’s intervals and
zero points over time.
The Zurich study is a longitudinal study of somatic and
psychopathology in adults from the community, spanning
over three decades from age 20 to 50. A diagnosis of adult
ADHD to validate the proposed SCL-ADHD scale unfor-
tunately is not available in the Zurich study, but full SCL-
90-R data have been obtained nine times during the study
period and so provide an ample database to examine the
longitudinal characteristics of the proposed scale.
Materials and methods
Subjects
Study subjects were recruited from patients with a DSM-IV
diagnosis of ADHD, consecutively presenting to the
ADHD consultation service at the Center of Addiction
Disorders, an outpatient facility of the Zurich University
Psychiatric Hospital, between September 2000 and January
2006. Complete data could be obtained from 100 out of
134 patients presenting to the service [15].
Sixty-five control subjects without an ADHD diagnosis
were recruited from opiate-dependent outpatients in meth-
adone or buprenophine maintenance therapy at the Center for
Addiction Disorders, in late 2005 [33]. Data on other kinds of
medication are not available for these subjects.
Procedure
All diagnostic assessments were made in both the patient
and the control group. A comprehensive diagnostic psy-
chiatric evaluation was based on ICD-10 criteria [35].
However, ADHD was diagnosed according to the Utah
criteria for diagnostic assessment with the Wender-Re-
imherr Interview (WRI) [34] translated to and validated for
the German language by Ro¨sler et al. and Retz-Junginger
et al. [24, 25, 28, 32]. These are the only criteria explicitly
formulated for adult ADHD and are compatible with DSM-
IV-TR ADHD criteria. There are no criteria for adult
ADHD in the ICD-10. Three ADHD subtypes were diag-
nosed according to DSM-IV-TR specifications: inattentive
subtype, hyperactive subtype, and mixed subtype.
All patients and controls received the German versions
of the Symptom Check List 90 Revised (SCL-90-R) [11,
12], the Wender Utah Rating Scale (WURS-k) [24, 25, 28]
and the Attention Deficit-/Hyperactivity Self-Report Scale
(ADHS-SB) [29], as part of the regular consultation.
In the case of unanswered questionnaire items, patients
were approached again and asked to supply the missing
information. When patients had difficulty answering a
question, their therapist helped clarifying it, so that an
answer could be arrived at. Auxiliary third-party informa-
tion to support the diagnostic procedure was sought out for
all patients, the main sources being family members,
spouses, school reports, and childhood medical reports.
Auxiliary information was more readily obtainable from
ADHD patients than from control subjects.
Complete information for the SCL-90-R was obtained
for 120 participants (66.2% controls, 77.0% ADHD
patients; P \ .13). 29 participants had only one missing
item, 13 had more than one but less than ten missing items,
and 3 had not filled out the questionnaire at all.
All subjects received a written description of the study
procedure and gave their informed consent by signature.
The study was approved by the local ethics committee.
Questionnaires
The Wender-Reimherr Interview (WRI) is the German
version of the American Wender-Reimherr Adult Attention
Deficits Disorders Scale (WRAADDS) for the assessment
of adult ADHD. It allows a diagnosis of adult ADHD to be
made. It contains seven scales for: attention difficulties,
persistent motor hyperactivity, temper, affective lability,
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emotional overreactivity, disorganization, and impulsivity.
Each scale is represented by 3–5 items. A sum score is
formed per scale, and each scale has a diagnostic threshold.
A diagnosis requires that sum scores for scales 1–2 must
each exceed their threshold and that for scales 3–7, 2 out of
5 sum scores must exceed their threshold.
The SCL-90-R is a self-report inventory of 90 symptoms
that characterize various psychiatric conditions. The degree
to which each symptom has been present in the past 7 days
is rated on a Likert scale from 0 to 4, coded in the fol-
lowing way: 0 = not at all, 1 = a little bit, 2 = moder-
ately, 3 = quite a bit, and 4 = extremely. The items can be
grouped into nine scales: anxiety, depression, hostility,
interpersonal sensitivity, obsessive–compulsive, paranoid
ideation, phobic anxiety, psychoticism, and somatization.
The scales are formed by summing up the ratings given to
each item belonging to the respective scale. The SCL-90-R
is customarily used to cover the past 7 days, but in the
present study, it was used to cover the past 4 weeks.
The WURS-k is the German short form of the Wender
Utah Rating Scale for the retrospective assessment in
adulthood of childhood ADHD [25]. It is a self-rating
instrument consisting of 25 items describing childhood
symptoms of ADHD, only 21 of which are used to form the
total score of the scale. The degree of endorsement of each
item is rated on five levels as follows: 0 = not at all,
1 = slightly, 2 = moderately, 3 = distinctly, and
4 = strongly. The scale showed an internal consistency of
0.91 (Cronbach’s alpha) [24] and a test–retest reliability of
between 0.87 and 0.97 depending on the sample [25].
The ADHS-SB is a self-rating instrument for the
assessment of adult ADHD in German [29]. It consists of
18 symptoms of ADHD derived from the DSM-IV and
ICD-10 criteria for ADHD. The degree of endorsement is
rated on four levels: 0 = not at all, 1 = slightly,
2 = moderately, and 3 = severely. The total score is
obtained by summing up the 18 individual item scores.
Subsyndrome scores for ‘‘attention deficit’’, ‘‘hyperactiv-
ity’’, and ‘‘impulsivity’’ can also be obtained. The internal
consistency of the main scale is 0.9 (Cronbach’s alpha)
[29]. Total scores of the ADHS-SB and the WURS-k have
been found to be statistically significantly correlated
(r = 0.58) [29].
The ADHD scale of the SCL-90-R
Based on the Wender Utah Rating Scale as well as on
clinical experience, nine items considered to be charac-
teristic of adult ADHD were selected from the SCL-90-R.
These included items 2, 9, 11, 24, 28, 55, 57, 74, and 78
(Table 3). A total score was formed by summing up the
individual item scores. The possible range of scores is
0–36.
Assessment of psychometric properties of the SCL-
ADHD scale in an independent epidemiological sample
The longitudinal behavior (measurement invariance/test–
retest reliability) as well as the internal consistency of the
SCL-ADHD scale were examined in an independent sam-
ple from a Swiss longitudinal community study, the
‘‘Zurich study’’. The Zurich study examines a wide range
of somatic and psychic complaints in adults from age
19–20 to age 49/50, using a comprehensive structured
interview applied by trained interviewers in participants’
homes. Seven interview waves have been conducted so far,
in the years 1979, 1981, 1986, 1988, 1993, 1999, and 2008.
For the first interview wave, 591 participants were selected
from a larger representative screening population consist-
ing of all male conscripts to the army (age 19, N = 2201)
and all women enrolled in the electoral register (age 20,
N = 2346) in the canton of Zurich, Switzerland.
Sample selection followed a stratified sampling proce-
dure, whereby the sample is enriched with cases at risk for
the development of psychiatric and/or somatic syndromes.
High risk subjects are defined by initial SCL-90-R total
scores (Global Severity Index scores) above the 85th per-
centile and make up 1/3 of the sample, while the low risk
group was randomly selected from subjects scoring below
the 85th percentile in the SCL-90-R. The resulting sample
consisted of 591 subjects (292 men, 299 women). Strati-
fication bias can be removed by well-established statistical
procedures to obtain population estimates [14]. The 591
subjects of the Zurich study thereby represent 2600 sub-
jects of age 19–20 from the general population of the
canton of Zurich.
The SCL-90-R was administered nine times during the
study: every year from 1978 to 1981, as well as in the years
1986, 1988, 1993, 1999, and 2008 (note that the 1978 data
were obtained from the initial screening sample which is
not part of the regular interviews that started in 1979).
Importantly, as in the clinical sample, the SCL was also
used to cover the past 4 weeks, not just the past 7 days as is
customary. Therefore, the SCL data of the clinical sample
and the Zurich study are comparable in this respect.
Apart from examining the measurement properties of
the scale, we also tentatively assessed sex differences in a
group of potential ADHD subjects. These subjects were
identified as those whose SCL-ADHD scores, averaged
intra-individually over all nine measurement points, were
equal to or above a cut-off value of 12 (which was inde-
pendently established in a ROC analysis; see below). For
the sake of simplicity, these subjects will be referred to as
‘‘SCL-ADHD high scorers’’. Given their tentative nature,
these analyses will be reported mostly in a qualitative
manner with only the core numerical findings being
presented.
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Statistical analysis
WURS-k, ADHS-SB, and SCL-ADHD total scores were
compared across groups by Kruskal–Wallis tests. A recei-
ver operating characteristic (ROC) analysis was used to
compute the sensitivity and specificity of the SCL-ADHD
scale to discriminate between a true and false ADHD
diagnosis as established by DSM-IV-TR compatible crite-
ria. The area under the ROC curve is reported as a global
measure of the total discriminatory power of the scale.
Cronbach’s alpha [10] and McDonald’s omega [27] served
as indicators of the internal consistency of the scale. Cor-
relations between different scales (SCL-ADHD, WURS-k,
ADHS-SB) were based on non-parametric Spearman cor-
relation coefficients.
In the Zurich study, the measurement properties of the
SCL-ADHD scale were assessed in three ways: by exam-
ining (1) measurement invariance over time, (2) test–retest
reliabilities, and (3) internal consistency. Measurement
invariance over time refers to a scale measuring the same
construct or content across different assessment times. This
is important because if it does not, the scale scores mea-
sured at different times will not be comparable because
they do have different meanings, that is, they do not relate
to the construct in the same way. The scale is then not a
reliable indicator of the underlying construct. The test–
retest correlation is the correlation between the scale scores
at two different assessment times and is another common
indicator of trans-temporal scale reliability.
Finally, we examined internal consistency as the pro-
portion of total scale variance due to both group factors and
general factors. Together, they account for a scale’s true-
score variability, that is, the variability in the underlying
construct the scale is intended to measure, as opposed to
variability due to measurement error and confounding
effects. This is what we, following Revelle and Zinbarg
[27], call internal consistency. We report both McDonald’s
omega total (x_t), a measure of internal consistency, and
McDonal’s omega hierarchical (x_h), a measure only of
the proportion of general (but not group) variability relative
to total scale variability. We do not support Cronbach’s
alpha because it has been shown to have a number of
serious shortcomings [36] that make it unsuitable as an
index for internal consistency. We merely report it for
comparability with other studies.
Measurement invariance across time was tested in a
series of exploratory and confirmatory factor analyses
using structural equation modeling. The principle of
invariance testing is to examine whether those parameters
of a scale that reflect its measurement properties—mainly
the factor loadings and the scale item intercepts—remain
constant across different testing occasions. In the present
case, the different testing occasions are the nine interviews
conducted over a period of 30 years.
The present data are ordinal and non-normal and were
estimated using a mean- and variance adjusted weighted
least squares (WLSMV) estimator, since maximum-likeli-
hood (ML) estimation can lead to biased parameter esti-
mates in skewed categorical data [6]. Correspondence of
the model to the data was assessed using chi-squared
testing as well as a series of commonly used statistical
indexes with recommended cut-off values indicating good
model fit: the comparative fit index (CFI; cut off C 0.95),
the Tucker-Lewis index (TLI, cut off C 0.95), and the root
mean square error of approximation (RMSEA, cut
off B 0.05). Differences in model fit between two succes-
sive CFA models were assessed using chi-squared tests and
comparisons of fit indexes [6]. However, there are no
agreed-upon standards for how to assess differences in
model fit with either method. Both the chi-squared test [6]
and the chi-squared difference test [5, 17] are known to be
overly sensitive to sample size. There have been sugges-
tions for how to use differences in a variety of fit indexes to
compare the fit of two models [8, 9, 20]. Unfortunately, no
recommendations for non-normal, categorical data are
available. We will therefore tentatively follow the recom-
mendation to consider differences in the CFI of 0.01 or less
and in the RMSEA of 0.015 or less to indicate agreement
between two models that have been obtained using ML
estimation in multivariate normal data [8, 9].
Missing data were filled in by multiple imputation using
an iterative Markov chain Monte Carlo (MCMC) method
based on multivariate normal data. This method can be
applied to categorical data using an approach involving
dummy coding followed by rounding of the imputed data
that was proposed by Allison [1]. Ten imputations were
computed and included in subsequent analysis. Due to
insufficient cell sizes in the highest item category of the
SCL-90-R, the highest and second-highest categories were
combined for purposes of multiple imputation and mea-
surement invariance testing.
Some analyses in the Zurich study such as invariance
testing were based on the stratified sample of 591 subjects;
these analyses will be referred to as ‘‘stratified’’ or
‘‘unweighted’’. When population estimates were desired,
sample stratification by risk group was offset using sam-
pling weights as described by Dunn [14]. This well-
established procedure yields population estimates of prev-
alence rates. This type of analyses will be referred to as
‘‘weighted’’.
Due to the small sample sizes, an analysis of ADHD
subtypes was not attempted.
Analyses were carried out in Stata 11.1 [31] and Mplus
5.1 [22].
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Results
Group characteristics
ADHD and opiate-dependent patients did not differ sig-
nificantly in age and sex, but ADHD patients had higher
levels of education and lower overall lifetime comorbidity,
which was mainly due to the higher level of substance
abuse in opiate-dependent patients. These results are
summarized in Table 1.
Among the 100 ADHD patients, 26 belonged to the
inattentive subtype, 7 to the hyperactive-impulsive sub-
type, and the majority, 67 subjects, to the mixed subtype.
Information on current and past medication was available
for 99 out of 100 ADHD patients. 70 patients received
stimulants at the time of testing: 66 received methylphe-
nidate, two d-amphetamine, and two modafinil (Table 2).
The SCL-ADHD scale in the two clinical groups
With the exception of item 24 (‘‘temper outbursts’’), all items
of the ADHD scale were rated significantly higher by ADHD
than by control patients (Table 3). Six of the ADHD items
were among those eight (out of all 90) SCL items, showing
the largest differences between ADHD and control group.
The mean intra-item difference between the two groups
across the 9 ADHD items was 0.64 (SD = 0.197). The mean
SCL-ADHD total score was significantly higher among
ADHD subjects (17.8, SD = 8.32) than among controls
(11.8, SD = 7.12; P \ 0.001).
SCL-ADHD scores were non-significantly higher among
women than men, both in the total sample (16.8 vs 14.5;
P \ .11) and within the ADHD sample (19.4 vs. 16.5;
P \ .09). There were no sex differences within the control
sample (11.8 vs 11.8, P \ .89). Age did not differ between
men (37.0 ± 10.11 years) and women (34.7 ± 10.33;
P \ .22).
Table 4 lists the sensitivities and specificities of all
possible cut points on the SCL-ADHD scale with regard to
the true DSM-IV-TR compatible diagnosis. A cut point of
C12 yielded a sensitivity of 75% and a specificity of 54%.
This means that for this cut point, the scale correctly
identified 69 out of 92 true ADHD cases, leaving 23 false
negatives (25.0%), and it correctly identified 33 out of 61
non-ADHD cases, leaving 28 false positives (46.0%). The
total discriminatory power of the scale as indexed by the
area under the ROC curve was 0.705. The scale had good
Table 1 Comparison of the ADHD and the patient control group
(methadone-substituted opiate-dependent patients)
Control ADHD P
N 65 100
N women 22 42
% women 33.9 42.0 .29
Age 34.5 (8.01) 37.2 (11.36) .09
Education % % .0001
School not completed 10.8 0
Compulsory school 20.0 14.0
Vocational school 36.9 30.0
High school 0.0 26.0
Technical university 3.8 18.0
College/university 0.0 12.0
Psychiatric lifetime
comorbidity (ICD-10)
% % .0001
None 1.7 30.0
Substance abuse 84.6 35.0
Bipolar disorder 0.0 2.0
Depressive disorder 20.0 26.0
Mood disorder (total) 20.0 28.0
Neurotic, stress-related,
somatoform disorder
4.6 15.0
Personality/behavioral
disorder
16.9 8.0
ADHD test scores Mean (±SD) Mean (±SD)
WURS-k 28.4 (±18.26) 38.6 (±13.40) .0001
ADHS-SB 16.0 (±11.91) 29.1 (±9.57) .0001
SCL-ADHD scale 11.8 (±7.18) 17.8 (±8.32) .0001
Table 2 Characteristics of the ADHD group
ADHD group (N = 100) %
ADHD subtype
Inattentive 26.0
Hyperactive-impulsive 7.0
Mixed 67.0
Stimulant medication
Never 22.2
Past 8.1
Current 69.7
Antidepressant medication
Never 53.1
Past 14.3
Current 32.7
Neuroleptic medication
Never 90.9
Past 3.0
Current 6.1
Current medication
None 15.2
Stimulants only 42.4
Antidepressants only 9.1
Stimulants ? antidepressants 23.2
Stimulants ? others 5.1
No stimulants 5.1
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internal consistency: Omega total (x_t) was 0.90, omega
hierarchical (x_h) was 0.76, and Cronbach’s alpha was
0.88.
SCL-ADHD scores correlated significantly with ADHS-
SB scores (Spearman’s Rho = .66, P \ .001, Figure 1)
and with WURS-k scores (Spearman’s Rho = .50,
P \ .001). ADHS-SB and WURS-k also correlated sig-
nificantly (Spearman’s Rho = .62, P \ .001).
Longitudinal stability of the SCL-ADHD scale
in the epidemiological sample
Missing data
Due to a dropout rate of about 10% per interview, the
proportion of missing values among SCL items increased
from between 0.5 and 8% in 1979 to 45% in 2008. Overall,
the average proportion of missing data was 26%.
Measurement invariance
The initial exploratory factor analysis (EFA) yielded a well
interpretable and theoretically meaningful 3-factor solution
(Table 5). The three factors were termed ‘‘nervousness’’,
‘‘impaired cognition’’, and ‘‘irritability’’, respectively. The
model showed an excellent fit to the data (v2 = 23.4,
df = 11, P = 0.016; CFI = 0.994, TLI = 0.995,
RMSEA = 0.015). Therefore, the following longitudinal
measurement invariance testing was based on these three
factors. Table 6 lists the series of models that were com-
pared, each being more constrained than the preceding one.
The first model tested for equality of factor structure across
time, that is, the question whether the same items reliably
load on the same factors in all interview years. This model
fitted the data reasonably well. The following models
successively added further constraints of measurement
parameters across time: first, the equality of factor loadings
and item intercepts, second, the equality of factor vari-
ances. As evident from Table 6, v2-difference testing
indicated in each case that models were not invariant,
whereas the fit indexes were all consistent with the models
being invariant.
Table 3 SCL-90-R items selected for the ADHD scale and mean
item scores for ADHD patients and opiate-dependent control subjects
Item
number
Description Control
(N = 65)
ADHD
(N = 97)
P
2 Nervousness or shakiness
inside
1.52 1.97 .03
9 Trouble remembering
things
1.49 2.02 .008
11 Feeling easily annoyed or
irritated
1.58 2.23 .002
24 Temper outbursts that you
could not control
1.13 1.47 .14
28 Feeling blocked in getting
things done
1.65 2.31 .002
55 Trouble concentrating 1.45 2.55 .0001
57 Feeling tense or keyed up 1.40 2.08 .002
74 Getting into frequent
arguments
0.72 1.37 .002
78 Feeling so restless you
couldn’t sit still
1.08 1.75 .003
Table 4 Sensitivity and specificity of the SCL-ADHD scale for
detecting adult ADHD, for all possible cut points of the scale
Cut point Sensitivity (%) Specificity (%)
C0 100.0 0.0
C1 100.0 3.3
C2 100.0 4.9
C3 98.9 6.6
C4 97.8 9.8
C5 95.7 16.4
C6 93.5 23.0
C7 90.2 26.2
C8 87.0 34.4
C9 84.8 36.1
C10 80.4 44.3
C11 75.0 45.9
C12 75.0 54.1
C13 72.8 54.1
C14 64.1 62.3
C15 63.0 67.2
C16 57.6 73.8
C17 54.4 75.4
C18 51.1 80.3
C19 46.7 80.3
C20 44.6 86.9
C21 37.0 86.9
C22 33.7 86.9
C23 30.4 90.2
C24 28.3 91.8
C25 25.0 91.8
C26 19.6 95.1
C27 19.6 96.7
C28 17.4 98.4
C29 13.0 98.4
C30 9.8 100.0
C31 6.5 100.0
C32 4.4 100.0
C33 3.3 100.0
C34 1.1 100.0
[34 0.0 100.0
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Test–retest reliabilities
For each factor, the correlation between successive inter-
view times was obtained from the last model of invariance
testing (the model imposing equality of factor variances).
All factors showed a roughly linear decrease in test–retest
reliability with time, due to the fact that the intervals
between interviews became longer as the study progressed.
For factor 1, correlations ranged from 0.45 (1999–2008) to
0.84 (1978–1979); for factor 2, they ranged from 0.53
(1988–1993) to 0.88 (1986–1988); and for factor 3, they
ranged from 0.41 (1999–2008) to 0.81 (1978–1979). All
factor correlations for all 1-year intervals were greater or
equal to 0.7 (Fig. 2).
Internal consistency and reliability
Omega total (x_t) was over 0.88 for all assessment years,
while omega hierarchical (x_h) varied between 0.66 in
1999 and 0.79 in 1979. Cronbach’s alpha was over 0.83 for
all assessment years, with a maximum of 0.86 in 1986.
Sex differences
In the unweighted (stratified) sample, there was a significant
female preponderance of SCL-ADHD high scores in five
out of nine interviews. The percentage of subjects showing
ADHD scores C12 ranged from 56% at age 19 to 17% at
age 50 among women and from 28% at age 20 to 11% at age
0
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SCL-90-R ADHD score
ADHD Control
Fig. 1 Association between total scores of the ADHS-SB and the
SCL-ADHD scale in a mixed sample of ADHD patients and opiate-
dependent controls. Spearman correlation is 0.66, P \ .0001
Table 5 Factor loadings from Exploratory Factor Analysis of SCL-
90-R items selected for the SCL-ADHD scale
Item
number
Description Factor
1
Factor
2
Factor
3
2 Nervousness or shakiness
inside
0.74 -0.03 -0.01
9 Trouble remembering things -0.20 0.73 0.00
11 Feeling easily annoyed or
irritated
0.19 -0.01 0.58
24 Temper outbursts that you
could not control
0.30 0.06 0.36
28 Feeling blocked in getting
things done
0.17 0.46 0.08
55 Trouble concentrating 0.01 0.87 -0.12
57 Feeling tense or keyed up 0.80 -0.01 0.00
74 Getting into frequent
arguments
-0.01 -0.01 0.77
78 Feeling so restless you
couldn’t sit still
0.43 0.08 0.18
Numbers in boldface are primary loadings. Factors 1–3 were termed
‘‘nervousness’’, ‘‘impaired cognition’’, and ‘‘irritability’’, respectively
Table 6 Statistical results of measurement invariance testing
Model constraintsa v2b df P CFI TLI RMSEA
Equal factor
structure
639.4 675 0.001 0.931 0.969 0.037
Equal loadings &
intercepts
197.0 73 0.001 0.926 0.965 0.040
Equal factor
variances
638.3 118 0.001 0.919 0.961 0.042
CFI comparative fit index, TLI Tucker-Lewis index, RMSEA root
mean square error of approximation
a Parameters were constrained to equality across assessment times
b Refers to the absolute v2 value for the first model (equal factor struc-
ture) and to the v2-difference to the preceding model for all other models
Fig. 2 Test–retest correlations for the three factors extracted from the
SCL-ADHD scale
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40 among men. Population estimates derived from the
weighted sample yielded significant sex differences in three
out of nine interviews, although prevalence rates in women
(around 15%) were consistently, if only slightly, above
those in men (around 8%). The average total prevalence of
SCL-ADHD high scorers was around 11%.
Discussion
The present report introduces a new SCL-90-R scale for
adult ADHD. The utility of the scale was evaluated in two
ways: first, by computing its diagnostic performance in a
mixed clinical sample consisting of confirmed ADHD
cases and opiate-dependent non-ADHD cases; second, by
assessing its psychometric properties, particularly its lon-
gitudinal stability, in the Zurich study, an epidemiological
cohort of adults from the community that was followed
over 30 years and for which nine assessments of the SCL-
90-R are available.
In the clinical sample, the SCL-ADHD scale correctly
identified 75% of true ADHD cases, giving a false negative
rate of 25%. It correctly identified 54% of non-ADHD
cases, giving a larger false positive rate of 46%. Its dis-
criminatory performance was comparable to a similar SCL-
90-R-based scale for mania proposed by Hunter et al. [16].
The nine SCL items selected for the scale at least partly
cover the three subtypes of ADHD as specified in the
DSM-IV: attention, hyperactivity, and impulsivity.
Although an exact correspondence between these items and
those of a specific adult ADHD scale like the ADHS-SB
cannot be expected, the present SCL-ADHD scale does not
leave out any relevant domain of impairment completely.
Furthermore, the substantial (Rho = 0.66) and significant
correlation between the SCL-ADHD and ADHS-SB sum
scores is encouraging.
Our analyses indicate that the proposed scale represents a
conceptually and empirically stable construct. Its internal
consistency was good, according to three different indexes
(one of which, Cronbach’s alpha, we do not consider a
trustworthy measure, however). It correlated substantially
with two other validated ratings for adult ADHD (WURS-k
and ADHS-SB). Its three factors ‘‘nervousness’’, ‘‘impaired
cognition,’’ and ‘‘irritability’’ replicated reliably across nine
assessment times covering 30 years of adult life. The total
scale proved to be quite stable longitudinally, justifying
some confidence that it captures true changes in ADHD
syndrome level over time, and not just measurement error
and other artifacts. Although one of the tests (the v2-test)
used to assess measurement invariance over time indicated a
lack of stability, this test is known for its significant short-
comings, and its use in such contexts has been questioned
[9]. We therefore base judgement of our scale’s temporal
stability on the comparison of fit indexes and on the high
test–retest reliabilities found for all three factors (r [ 0.7 for
all one-year test intervals). However, it must be noted that
the statistical assessment of longitudinal change in psycho-
metric scales is very much a science in progress, and no final
word on which approach is the best will be spoken soon.
Therefore, results must be consumed with caution.
Tentatively assuming that subjects in the Zurich study
with high average SCL-ADHD scores comprise an appre-
ciable proportion of true ADHD cases, we examined sex
differences with respect to this group. Sex differences in
the proportion of SCL-ADHD high scorers were not con-
sistently found. This is in line with the findings from the
clinical sample showing non-significantly higher scores in
women and with previous reports that sex differences in
ADHD prevalence and symptom characteristics diminish in
adulthood [4, 26].
The SCL-90-R is used worldwide and is available in
many languages. One of its typical uses is in a clinical
setting to assess the longitudinal course and outcome in
treatment studies. More recently, it has also been integrated
into epidemiological studies. Given this questionnaire’s
wide application, we believe that the proposed ADHD
scale can be useful in clinical and research contexts. We
can envisage at least two important scenarios: first, a
researcher wishes to retrospectively assess an existing
SCL-90-R data set, perform a rough identification of pos-
sible ADHD cases using our scale, and identify possible
correlations with other variables of interest. This may even
yield some added explanatory value, as when for example
non-response in a medication study can be retrospectively
accounted for by the previously undeteced presence of an
ADHD syndrome in treatment-refractory patients. Second,
a researcher planning a prospective study is limited by
practical or substantive constraints to include a specific
instrument for ADHD, but is able to include the SCL-90-R
as a multipurpose instrument that will then allow, using our
scale, to identify potential ADHD cases and explore pos-
sible interesting relations that might be followed up by
more specific investigation. To further its utility, we pres-
ent here full information on all cut points of the scale so
that researchers and clinicians have the possibility to
choose the cut point most useful to them depending on
whether their emphasis is on sensitivity or specificity. We
hope that the proposed scale can be further evaluated,
specifically its discriminatory performance in various
populations and its reliability and construct validity.
Limitations: The design of the proposed scale reveals its
obvious limitations. The presence of ADHD is inferred
from a very small item base. More seriously, neither the
questionnaire from which the items are drawn nor the items
itself were specifically selected to assess symptoms of
ADHD. Undesired consequences would arise from taking
526 Eur Arch Psychiatry Clin Neurosci (2012) 262:519–528
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our scale as a replacement for an existing, ADHD-specific
scale. It clearly is not.
With a sensitivity of 75% and a specificity is 54%,
using the scale as a screening instrument will fail to
identify 25% of true ADHD cases (false negatives), while
a full 46% of non-cases will be falsely identified as
ADHD cases (false positives). Therefore, while one use of
the scale is to flag some subjects as potential ADHD
cases, these subjects must then be followed up with a
specific diagnostic instrument such as the WRI or the
WRAADDS.
The proposed scale works by the principle that it is
better to have some limited data than to have no data at all,
provided the limited data are reliable. In this regard, the
results for the proposed scale are certainly encouraging.
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